2251 related articles for article (PubMed ID: 29843220)
21. Knockdown of Long Noncoding RNA GHET1 Inhibits Cell Proliferation and Invasion of Colorectal Cancer.
Zhou J; Li X; Wu M; Lin C; Guo Y; Tian B
Oncol Res; 2016; 23(6):303-9. PubMed ID: 27131316
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.
Eroğlu Güneş C; Güçlü E; Vural H; Kurar E
Gene; 2021 Dec; 805():145904. PubMed ID: 34418470
[TBL] [Abstract][Full Text] [Related]
23. LncRNA CASC2 expression is down- regulated in papillary thyroid cancer and promotes cell invasion by affecting EMT pathway.
Zhou T; Zhong M; Zhang S; Wang Z; Xie R; Xiong C; Lv Y; Chen W; Yu J
Cancer Biomark; 2018; 23(2):185-191. PubMed ID: 30175973
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA HOTAIR functions as miRNA sponge to promote the epithelial to mesenchymal transition in esophageal cancer.
Xu F; Zhang J
Biomed Pharmacother; 2017 Jun; 90():888-896. PubMed ID: 28441714
[TBL] [Abstract][Full Text] [Related]
25. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines.
Jafari-Oliayi A; Asadi MH
Cell Oncol (Dordr); 2019 Apr; 42(2):211-221. PubMed ID: 30826970
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition.
Liu J; Lu C; Xiao M; Jiang F; Qu L; Ni R
Biomed Pharmacother; 2017 May; 89():857-863. PubMed ID: 28282787
[TBL] [Abstract][Full Text] [Related]
27. Up-regulation of long intergenic noncoding RNA 01296 in ovarian cancer impacts invasion, apoptosis and cell cycle distribution via regulating EMT.
Xu H; Zheng JF; Hou CZ; Li Y; Liu PS
Cell Signal; 2019 Oct; 62():109341. PubMed ID: 31176022
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA VIM-AS1 promotes prostate cancer growth and invasion by regulating epithelial-mesenchymal transition.
Zhang Y; Zhang J; Liang S; Lang G; Liu G; Liu P; Deng X
J BUON; 2019; 24(5):2090-2098. PubMed ID: 31786880
[TBL] [Abstract][Full Text] [Related]
29. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
30. Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
Fan Y; Wang YF; Su HF; Fang N; Zou C; Li WF; Fei ZH
J Hematol Oncol; 2016 Jul; 9(1):57. PubMed ID: 27439973
[TBL] [Abstract][Full Text] [Related]
31. The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer.
Ma S; Deng X; Yang Y; Zhang Q; Zhou T; Liu Z
Biomed Pharmacother; 2018 Dec; 108():1686-1693. PubMed ID: 30372871
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer.
Zhao J; Liu Y; Zhang W; Zhou Z; Wu J; Cui P; Zhang Y; Huang G
Cell Cycle; 2015; 14(19):3112-23. PubMed ID: 26237576
[TBL] [Abstract][Full Text] [Related]
34. Long noncoding RNA GHET1 promotes the development of bladder cancer.
Li LJ; Zhu JL; Bao WS; Chen DK; Huang WW; Weng ZL
Int J Clin Exp Pathol; 2014; 7(10):7196-205. PubMed ID: 25400817
[TBL] [Abstract][Full Text] [Related]
35. [Low expression of lncRNA-GAS5 promotes epithelial-mesenchymal transition of breast cancer cells in vitro].
Ding YX; Duan KC; Chen SL
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1427-1435. PubMed ID: 29180320
[TBL] [Abstract][Full Text] [Related]
36. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of long non-coding RNA PlncRNA-1 promotes proliferation and induces epithelial-mesenchymal transition in prostate cancer.
Jin Y; Cui Z; Li X; Jin X; Peng J
Oncotarget; 2017 Apr; 8(16):26090-26099. PubMed ID: 28212533
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
Tuo Z; Zhang J; Xue W
Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
[TBL] [Abstract][Full Text] [Related]
39. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
40. The high expression of long non-coding RNA PANDAR indicates a poor prognosis for colorectal cancer and promotes metastasis by EMT pathway.
Lu M; Liu Z; Li B; Wang G; Li D; Zhu Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):71-81. PubMed ID: 27629879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
